Patents by Inventor André Beaulieu

André Beaulieu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Deepithelialized skin diffusion cell system
    Patent number: 5877149
    Abstract: A deepithelialized skin cell diffusion system which can be used to select topical gel and cream formulations containing human other wound healing promoters such as plasma fibronectin. The formulations provide slow release and increased contact time of fibronectin or other wound healing promoters to the wound site leading to its effective absorption.
    Type: Grant
    Filed: June 19, 1997
    Date of Patent: March 2, 1999
    Inventor: Andre Beaulieu
  • Method of producing concentrated non-buffered solutions of fibronectin
    Patent number: 5821220
    Abstract: Topical gel and cream formulations containing human plasma fibronectin and other wound healing promoters are used for the healing of cutaneous wounds. The formulations provide slow release and increased contact time of fibronectin and of other wound healing promoters to the wound site leading to the effective absorption of the promoters.
    Type: Grant
    Filed: December 17, 1996
    Date of Patent: October 13, 1998
    Assignee: Andre Beaulieu
    Inventors: Andre Beaulieu, Robert Paquin
  • Wound healing formulations containing human plasma fibronectin
    Patent number: 5641483
    Abstract: Topical gel and cream formulations containing human plasma fibronectin are used for the healing of cutaneous wounds. The formulations provide slow release and increased contact time of fibronectin to the wound site leading to effective absorption of an effective wound healing amount of fibronectin in the skin.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 24, 1997
    Inventor: Andre Beaulieu